866-997-4948(US-Canada Toll Free)

Caspofungin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Published By :

Transparency Market Research

Published Date : Apr 2019

Category :

Pharmaceutical

No. of Pages : 156 Pages

Caspofungin Market: Overview

This report on the global caspofungin market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a snapshot that provides overall information of various market segments. The research is a combination of primary and secondary researches. Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2017 to 2027, considering the macro and micro environmental factors. Growth rate for each segment of the global caspofungin market has been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. The report also provides insights into the key trends of the caspofungin market. The report includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global caspofungin market.

Market revenue in terms of US$ Mn for the period between 2017 and 2027 along with the compound annual growth rate (CAGR %) from 2019 to 2027 are provided for all the segments, considering 2018 as the base year. The year-on-year growth of the global caspofungin market for each segment is also reflected. Additionally, market-related factors such as favorable reimbursement scenario, expanding distribution channels of caspofungin, and historical year-on-year growth have been taken into consideration while estimating the market size.

Global Caspofungin Market: Key Segments

Based on indication, the global caspofungin market has been segmented into candidiasis and thrush. In terms of distribution channel, the global market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.

Global Caspofungin Market: Regional Outlook

In terms of region, the global caspofungin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been divided into major countries/sub-regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia & New Zealand, Japan, India, Brazil, GCC Countries, South Africa, Israel, and Mexico.

Companies Mentioned in Report

The report also profiles major players in the global caspofungin market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Teva Pharmaceutical Industries Ltd., Mylan N.V , Merck & Co., Inc., Fresenius SE & Co. KGaA, Gland Pharma Limited, Xellia Pharmaceuticals, and Novartis AG.

The global caspofungin market has been segmented as follows:

Global Caspofungin Market, by Indication

  • Candidiasis
  • Thrush

Global Caspofungin Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Caspofungin Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • Australia & New Zealand
  • Japan
  • China
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Caspofungin Market Snapshot
3.2 Key Industry Developments

Section 4 Market Overview
4.1 Caspofungin Market Taxonomy
4.2 Caspofungin Drug Introduction
4.3 Global Caspofungin Market Size (US$ Mn) Forecast, 2017–2027
4.4 Global Caspofungin Market: Market Outlook
4.5 Rise in incidence of invasive candidiasis across the globe
4.5.1.Rise in geriatric population
4.5.2.Advantages of echinocandins over other antifungal
4.5.3.Restraints
4.5.3.1 Availability of Generic Drugs
4.5.3.2 Emergence of resistant species
4.5.4 Opportunities
4.5.4.1 Echinocandins, as first line of therapy in candidiasis
4.5.4.2 Expansion of Research and Development in Emerging Markets

Section 5 Key Insights
5.1 Clinical Trial Pipeline Analysis
5.2 Disease Prevalence & Incidence Rate globally with key countries
5.3 Supply Chain Analysis
5.4 Pricing Analysis by Manufacturers

Section 6 Global Caspofungin Market Analysis, by Indication
6.1 Key Findings
6.2 Introduction
6.3 Market Value Share Analysis, by Indication
6.4 Market Value Forecast, by Indication, 2017–2027
6.5 Market Analysis, by Indication, 2017–2027
6.5.1 Candidiasis
6.5.2 Thrush
6.6 Market Attractiveness, by Indication 

Section 7 Global Caspofungin Market Analysis, by Distribution Channel
7.1 Key Findings
7.2 Introduction
7.3 Market Value Share Analysis, by Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2 Retail Pharmacies
7.5.3 Online Pharmacies
7.6 Market Attractiveness, by Distribution Channel 

Section 8 Global Caspofungin Market Analysis, by Region
8.1 Market Value Share Analysis, by Region
8.2 Market Forecast, by Region
8.3 Global Caspofungin Market Attractiveness Analysis, by Region

Section 9 North America Caspofungin Market Analysis
9.1 Market Overview
9.2 Market Value Share Analysis, by Indication
9.3 Caspofungin Market Forecast, by Indication
9.4 Market Value Share Analysis, by Distribution Channel
9.5 Caspofungin Market Forecast, by Distribution Channel
9.6 U.S.
9.6.1 Canada
9.7 Market Attractiveness Analysis
9.7.1 By Country
9.7.2 By Indication
9.7.3 By Distribution Channel

Section 10 Europe Caspofungin Market Analysis
10.1 Market Overview
10.2 Market Value Share Analysis, by Indication
10.3 Caspofungin Market Forecast, by Indication
10.4 Market Value Share Analysis, by Distribution Channel
10.5 Caspofungin Market Forecast, by Distribution Channel
10.6 Market Value Share Analysis, by Country/Sub-region
10.7 Market Forecast, by Country/Sub-region
10.7.1 Germany
10.7.2 U.K.
10.7.3 France
10.7.4 Spain
10.7.5 Italy
10.7.6 Rest of Europe
10.8 Market Attractiveness Analysis
10.8.1 By Country/Sub-region
10.8.2 By Indication
10.8.3 By Distribution Channel

Section 11 Asia Pacific Caspofungin Market Analysis
11.1 Market Overview
11.2 Market Value Share Analysis, by Indication
11.3 Caspofungin Market Forecast, by Indication
11.4 Market Value Share Analysis, by Distribution Channel
11.5 Caspofungin Market Forecast, by Distribution Channel
11.6 Market Value Share Analysis, by Country/Sub-region
11.7 Market Forecast, by Country/Sub-region
11.7.1 China
11.7.2 Japan
11.7.3 India
11.7.4 Australia & New Zealand
11.7.5 Rest of Asia Pacific
11.8 Market Attractiveness Analysis
11.8.1 By Country/Sub-region
11.8.2 By Indication
11.8.3 By Distribution Channel

Section 12 Latin America Caspofungin Market Analysis
12.1 Market Overview
12.2 Market Value Share Analysis, by Indication
12.3 Caspofungin Market Forecast, by Indication
12.4 Market Value Share Analysis, by Distribution Channel
12.5 Caspofungin Market Forecast, by Distribution Channel
12.6 Market Value Share Analysis, by Country/Sub-region
12.7 Market Forecast, by Country/Sub-region
12.7.1 Brazil
12.7.2 Mexico
12.7.3 Rest of Latin America
12.8 Market Attractiveness Analysis
12.8.1 By Country/Sub-region
12.8.2 By Indication
12.8.3 By Distribution Channel

Section 13 Middle East & Africa (MEA) Caspofungin Market Analysis
13.1 Market Overview
13.2 Market Value Share Analysis, by Indication
13.3 Caspofungin Market Forecast, by Indication
13.4 Market Value Share Analysis, by Distribution Channel
13.5 Caspofungin Market Forecast, by Distribution Channel
13.6 Market Value Share Analysis, by Country/Sub-region
13.7 Market Forecast, by Country/Sub-region
13.7.1 GCC Countries
13.7.2 South Africa
13.7.3 Israel
13.7.4 Rest of MEA
13.8 Market Attractiveness Analysis
13.8.1 By Country/Sub-region
13.8.2 By Indication
13.8.3 By Distribution Channel

Section 14 Company Profiles
14.1 Market Player - Competition Matrix (By Tier and Size of companies)
14.2 Market Share Analysis, by Company, 2017
14.3 Company Profile
14.3.1 Teva Pharmaceutical Industries Ltd.
14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2 Financial Overview
14.3.1.3 Product Portfolio
14.3.1.4 SWOT Analysis
14.3.1.5 Strategic Overview
14.3.2 Novartis AG
14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2 Financial Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.2.4 Strategic Overview
14.3.3 Mylan N.V.
14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2 Financial Overview
14.3.3.3 Product Portfolio
14.3.3.4 SWOT Analysis
14.3.3.5 Strategic Overview
14.3.4 Merck & Co., Inc. 
14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2 Financial Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.4.4 Strategic Overview
14.3.5 Fresenius SE & Co. KGaA 
14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2 Financial Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.5.4 Strategic Overview
14.3.6 Gland Pharma Limited (Shanghai Fosun Pharmaceutical (Group) Co., Ltd.)
14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2 Financial Overview
14.3.6.3 Product Portfolio
14.3.6.4 SWOT Analysis
14.3.6.5 Strategic Overview
14.3.7 Xellia Pharmaceuticals 
14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2 Financial Overview
14.3.7.3 Product Portfolio
14.3.7.4 SWOT Analysis
14.3.7.5 Strategic Overview

List of Table

List of Table

Table 01: Caspofungin Brands in India and their Prices
Table 02: Caspofungin Brands in Germany and their Prices
Table 03: Pipeline Analysis, by Phase 3 Drugs
Table 04: Country Estimated Burden and Prevalence Rate of Candidiasis 
Table 05: List of Prescription Products
Table 06: List of Prescription Products
Table 07: List of Generic Prescription Products
Table 08: Global Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 09: Global Caspofungin Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 10: Global Caspofungin Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11: North America Caspofungin Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 12: North America Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 13: North America Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 14: Europe Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Europe Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 16: Europe Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 17: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 19: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 20: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 22: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 23: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 25: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

List of Chart

List of Figures

Figure 01: Global Caspofungin Market Snapshot
Figure 02: Global Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 03: Market Value Share, by Indication, 2018
Figure 04: Market Value Share, by Distribution Channel, 2018
Figure 05: Market Value Share, by Region, 2018
Figure 06: Global Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 07: Global Caspofungin Market Revenue (US$ Mn) Forecast, by Candidiasis, 2019–2027 
Figure 08: Global Caspofungin Market Revenue (US$ Mn) Forecast, by Thrush, 2019–2027
Figure 09: Global Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 10: Global Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 11: Global Caspofungin Market Revenue (US$ Mn), by Hospital Pharmacies, 2017–2027
Figure 12: Global Caspofungin Market Revenue (US$ Mn), by Retail Pharmacies, 2017–2027
Figure 13: Global Caspofungin Market Revenue (US$ Mn), by Online Pharmacies, 2017–2027
Figure 14: Global Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 15: Global Caspofungin Market Value Share, by Region, 2018 and 2027
Figure 16: Global Caspofungin Market Attractiveness, by Region, 2019–2027
Figure 17: North America Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 18: North America Caspofungin Market Value Share, by Country, 2018 and 2027
Figure 19: North America Caspofungin Market Attractiveness, by Country, 2019–2027
Figure 20: North America Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 21: North America Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 22: North America Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 23: North America Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 24: Europe Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 25: Europe Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 26: Europe Caspofungin Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 27: Europe Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 28: Europe Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 29: Europe Caspofungin Market Value Share Analysis, by Distribution Channel
Figure 30: Europe Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 31: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 32: Asia Pacific Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 33: Asia Pacific Caspofungin Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 34: Asia Pacific Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 35: Asia Pacific Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 36: Asia Pacific Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027 
Figure 37: Asia Pacific Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 38: Latin America Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 39: Latin America Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 40: Latin America Caspofungin Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 41: Latin America Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 42: Latin America Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 43: Latin America Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 44: Latin America Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 45: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 46: Middle East & Africa Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 47: Middle East & Africa Caspofungin Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 48: Middle East & Africa Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 49: Middle East & Africa Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 50: Middle East & Africa Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 51: Middle East & Africa Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 52: Teva Pharmaceutical Industries Ltd., Generic Products Revenue (US$ Mn), 2015–2018
Figure 53: Teva Pharmaceutical Industries Ltd., Generic Products Breakdown of Net Sales (%), by Business Segment, 2018
Figure 54 Teva Pharmaceutical Industries Ltd., R&D Expenses (US$ Mn), 2015–2018
Figure 55: Teva Pharmaceutical Industries Ltd. Breakdown of Generic Products Net Sales (%), by Region, 2018
Figure 56: Sandoz Division Revenue (US$ Mn), 2015–2018
Figure 57: Sandoz Division Breakdown of Net Sales (%), by Region, 2018
Figure 58: Novartis AG, R&D Expenses (US$ Mn), 2015–2018
Figure 59: Novartis AG, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 60: Mylan N.V. Revenue (US$ Mn), 2015–2018
Figure 61: Mylan N.V., Breakdown of Net Sales (%), by Region, 2018
Figure 62: Mylan N.V., R&D Expenses (US$ Mn), 2015-2018
Figure 63: Merck & Co., Inc., Revenue (US$ Mn), 2015–2018
Figure 64: Merck & Co., Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 65: Merck & Co., Inc., R&D Expenses (US$ Mn), 2015–2017
Figure 66: Merck & Co., Inc., Breakdown of Net Sales (%), by Business Segment, 2017
Figure 67: Fresenius Kabi AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 68: Fresenius Kabi AG, Breakdown of Net Sales, by Region, 2018
Figure 69: Fresenius Kabi AG, R&D Expenses (US$ Mn), 2015–2018
Figure 70: Fresenius Kabi AG, Breakdown of Net Sales, by Product Segment, 2018
Figure 71: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Revenue (US$ Mn), 2015–2017
Figure 72: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 73: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., R&D Expenses (US$ Mn), 2015–2017
Figure 74: Xellia Pharmaceuticals Revenue (US$ Mn), 2015–2018
Figure 75: Xellia Pharmaceuticals, Breakdown of Net Sales (%), by Region, 2018
Figure 76: Xellia Pharmaceuticals, R&D Investment (US$ Mn), 2015–2018
Figure 77: Xellia Pharmaceuticals, Breakdown of Net Sales (%), by Business Segment, 2018

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *